Home Antibody All anti-SULT1A1 antibodies
Anti-SULT1A1 TRUEMAB Antibody clone 8B8
TrueMAB Antibodies - Made against Authentic Protein Antigens
Also for SULT1A1 (NM_001055)
|Full length human recombinant protein of human SULT1A1 (NP_001046) produced in HEK293T cell.|
|WB, IHC, FC
||WB 1:500~2000, IHC 1:150, FLOW 1:100
|PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.|
|Purified from mouse ascites fluids by affinity chromatography (Protein A or G Sepharose)
|Homo sapiens sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (SULT1A1), transcript variant 1|
|HAST1/HAST2; P-PST; PST; ST1A1; ST1A3; STP; STP1; TSPST1|
|Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. This gene encodes one of two phenol sulfotransferases with thermostable enzyme activity. Multiple alternatively spliced variants that encode two isoforms have been identified for this gene. [provided by RefSeq].|
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SULT1A1 (RC201601, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SULT1A1.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-SULT1A1 mouse monoclonal antibody. (TA501820)
HEK293T cells transfected with either RC201601 overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by anti-SULT1A1 antibody(TA501820), and then analyzed by flow cytometry.
Flow cytometric Analysis of Jurkat cells, using anti-SULT1A1 antibody(TA501820),(Red), compared to a nonspecific negative control antibody(TA50011),(Blue).